Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
LINC 25: The PATCH Study
Author(s): Sean Lyden Added: 1 year ago
LINC Conference 2025 - 30 day results of the PATCH study suggests the PerQSeal vascular closure device (Vivasure Medical Limited) can be used as an alternative percutaneous procedure for large-bore common femoral access, showing low risk of haematoma and a medium time of 0 minutes to achieve vessel closure.Dr Sean Lyden (Cleveland Clinic, Cleveland, OH, US) joins us to discuss the PATCH single… View more

Intervention

Vascular Disease and Surgery
Emergency Bedside Closure of Atrial Septal Defect Without Fluoroscopy
Author(s): Hamza Naveed , Laith M Haj-Ahmad , Pranav Loyalka Added: 7 months ago

Intervention

Heart Failure
Left Atrial Appendage to Circumflex Fistula Following Amulet Device
Author(s): Timothy John Bagnall , Christopher James Broyd , David Hildick-Smith Added: 1 year ago

Intervention
Echocardiography After PFO Closure
Author(s): Maja Rojko , Natasa Cernic Suligoj , Bojana Zvan , et al Added: 4 months ago

Imaging & Diagnostics

Intervention
Percutaneous Closure of an Aortopulmonary Window in an Adult Woman
Author(s): Felipe Eduardo Macías Prado , Jhon Mario German Gaibor , Rafel Ernesto Portaluppi Cervantes , et al Added: 6 months ago

Imaging & Diagnostics

Intervention
TSP in Patients with ASO
Author(s): Gerardo Lo Russo , Roberto Nerla , Angela Sanseviero , et al Added: 6 months ago

Intervention
PFO Closure: BCIS Position Statement
Author(s): Mark Turner , Suneil Aggarwal , Michael J Mullen , et al Added: 1 year ago

Intervention
ABSORB: Final Outcomes With the Absorb Bioresorbable Vascular Scaffold
Author(s): David Power Added: 1 year ago
Outcomes investigating the Absorb bioresorbable vascular scaffold (BVS) in patients undergoing percutaneous coronary intervention showed more adverse ischaemic events through 5 years compared with cobalt-chromium everolimus-eluting stents. However, the period of excess risk ended at 3 years.In this short interview, Dr David Power (Mount Sinai Hospital, New York, US) discusses the final report… View more

Intervention

Prevention & Chronic Conditions
TCT 25: Short-Term Anticoagulation Vs DAPT for Preventing Device Thrombosis Following LAAC
Author(s): Josep Rodés-Cabau Added: 7 months ago
TCT 2025 - Short-term anticoagulation reduced adverse events following left atrial appendage closure (LAAC) compared to dual antiplatelet therapy (DAPT).Dr Josep Rodés-Cabau (Quebec Heart and Lung Institute, Quebec, CA) joins us at TCT 2025 to discuss findings from ANDES trial (NCT03568890) investigating the safety and efficacy of short-term anticoagulation versus DAPT for preventing device… View more

Anticoagulation

Imaging & Diagnostics